Fig. 1From: Impact of the epidermal growth factor receptor mutation status on the prognosis of recurrent adenocarcinoma of the lung after curative surgeryMedian RFS was significantly better for lung adenocarcinoma patients with Mt than Wt; median RFS were 20.2 months and 13.3 months, respectively (p < 0.001)Back to article page